Written by Tavishi Dogra | Updated : February 17, 2023 8:57 AM IST
The fourth most frequent malignancy among women worldwide is cervical cancer. Around 90% of all new cases globally are likely to occur in low- and middle-income nations.
Strains 16 and 18 are responsible for nearly 50% of high-grade cervical cancers.
Sex workers are at very high-risk people who have multiple sexual partners are also prone to further risk.
Cervical cancer is six times more likely to strike women with HIV and HBsAg than those without the virus.
Additionally, the HPV vaccine can protect against the anal and oropharyngeal cancers that homosexuality is susceptible to.
If cervical cancer is detected relatively early and treated quickly, it can be cured—diagnosis and treatment of invasive cervical cancer, which constitutes tertiary prevention.
Comprehensive cervical cancer control comprises secondary prevention—screening and treatment of precancerous lesions—and primary prevention, HPV vaccine.
To prevent cervical cancer, which recommends immunising because most have not begun sexual activity, HPV vaccinations are most effective before HPV exposure.
The 90-70-90 targets were established by WHO and must be met by 2030 to continue. 90% of girls receive their final HPV vaccination by age 15.
By 35 and again by 45, 70% of women are subjected to high-performance tests. 90% of female patients with cervical illness received care.
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Refresh Page